Clinical Trial Update: S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study (S9911) evaluating the combination of chemotherapy plus monoclonal antibody therapy for patients with Non-Hodgkin lymphoma has completed. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED